is founder and CEO of Trias Pharma GmbH. Trias Pharma is a specialised consultancy company in the field of pharmaceutical product development with a focus on CMC development services. During his more than 25-year career in the industry, he has designed and built international R&D teams and business development organisations from scratch within the companies Glatt Pharmaceutical Services, ADD Technologies Ltd. and Aenova in the areas of pharmaceutical and analytical development, drug regulatory affairs and clinical trials. As founder and co-partner of Fidelio Healthcare Management Beteiligungs GmbH, Armin Prasch coordinates the strategic direction of the development projects of Fidelio Healthcare Limburg GmbH, a pharmaceutical contract manufacturer. Armin Prasch is on the board of the Branchenverband der Cannabiswirtschaft e.V. (German Cannabis Business Association, BvCW), where he heads the Medicinal Cannabis Division, and he is a member of the "Medicinal Cannabis" expert group under the umbrella of the DPhG. Armin Prasch studied process engineering at the Technical University of Munich and completed his doctorate in the field of biotechnology.